Stockscreener 앱 받기
72.93
0.59%
-0.43
시간 외 거래:
72.93
전일 마감가:
$73.36
열려 있는:
$72.77
하루 거래량:
4.33M
Relative Volume:
1.00
시가총액:
$42.82B
수익:
$5.69B
순이익/손실:
$1.41B
주가수익비율:
10.44
EPS:
6.9828
순현금흐름:
$577.90M
1주 성능:
-3.71%
1개월 성능:
-4.10%
6개월 성능:
+3.07%
1년 성능:
+5.85%
1일 변동 폭
$72.40
$73.83
1주일 범위
$72.30
$75.88
52주 변동 폭
$64.89
$83.00
에드워즈라이프사이언시스 Stock (EW) Company Profile
명칭
Edwards Lifesciences Corp
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA
EW을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
72.93 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
|
ABT
Abbott Laboratories
|
129.45 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.71 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.75 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.34 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
에드워즈라이프사이언시스 Stock (EW) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-07-29 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-04-24 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | 업그레이드 | Stifel | Hold → Buy |
| 2025-01-16 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-11 | 재개 | Morgan Stanley | Equal-Weight |
| 2024-09-18 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-07-31 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-07-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2024-07-25 | 다운그레이드 | Truist | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-03-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-02-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-12-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-11-28 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-03-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | 다운그레이드 | Bernstein | Outperform → Underperform |
| 2023-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-10-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 개시 | Mizuho | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-27 | 재확인 | Citigroup | Buy |
| 2022-01-27 | 재확인 | Evercore ISI | Outperform |
| 2022-01-27 | 재확인 | Raymond James | Outperform |
| 2022-01-27 | 재확인 | Stifel | Buy |
| 2022-01-27 | 재확인 | UBS | Neutral |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-12-06 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 재확인 | Canaccord Genuity | Buy |
| 2021-07-30 | 재확인 | Deutsche Bank | Hold |
| 2021-07-30 | 재확인 | Jefferies | Buy |
| 2021-07-30 | 재확인 | Morgan Stanley | Overweight |
| 2021-07-30 | 재확인 | Oppenheimer | Outperform |
| 2021-07-30 | 재확인 | Stifel | Buy |
| 2021-07-30 | 재확인 | UBS | Neutral |
| 2021-07-30 | 재확인 | Wells Fargo | Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Neutral |
| 2021-04-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-11 | 재확인 | Canaccord Genuity | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Underperform |
| 2020-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Outperform |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 재확인 | Canaccord Genuity | Buy |
| 2019-09-23 | 개시 | Piper Jaffray | Overweight |
| 2019-07-24 | 재확인 | BofA/Merrill | Buy |
| 2019-03-18 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Hold |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-16 | 개시 | Barclays | Underweight |
| 2018-10-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
모두보기
에드워즈라이프사이언시스 주식(EW)의 최신 뉴스
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW - GlobeNewswire Inc.
How high can Edwards Lifesciences Corporation stock goIndex Update & Proven Capital Preservation Methods - newser.com
Is Edwards Lifesciences Corporation stock a good choice for value investorsVolume Spike & Community Verified Swing Trade Signals - newser.com
Leerink Partners Adjusts Price Target on Edwards Lifesciences to $84 From $85, Maintains Market Perform Rating - MarketScreener
Mizuho Adjusts Price Target on Edwards Lifesciences to $90 From $95, Maintains Outperform Rating - MarketScreener
What is the fair value of Edwards Lifesciences Corporation stock nowWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
Aberdeen Group plc Increases Position in Edwards Lifesciences Corporation $EW - MarketBeat
OFI Invest Asset Management Has $26.57 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Callan Family Office LLC Boosts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
EW Investor News: Rosen Law Firm Investigates Breaches of - GlobeNewswire
Real time breakdown of Edwards Lifesciences Corporation stock performanceGDP Growth & Weekly Market Pulse Updates - newser.com
Ranking Edwards Lifesciences Corporation among high performing stocks via toolsPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com
Blair William & Co. IL Has $30.51 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
What machine learning models say about Edwards Lifesciences CorporationWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Visual trend scoring systems applied to Edwards Lifesciences Corporation2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Vontobel Holding Ltd. Reduces Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline - Yahoo Finance
Edwards Lifesciences (NYSE:EW) Given "Hold (C)" Rating at Weiss Ratings - MarketBeat
Here's What to Expect From Edwards Lifesciences’ Next Earnings Report - MSN
Edwards Lifesciences Leads Healthcare Stocks in S&P 500 - Kalkine Media
Edwards Lifesciences' Long-Term Plan Raises Concerns Amid 'Structural' Risks, Oppenheimer Says - MarketScreener
Edwards Lifesciences (NYSE:EW) Upgraded at Evercore ISI - MarketBeat
Edwards Lifesciences stock downgraded by Oppenheimer on structural concerns - Investing.com
Oppenheimer Downgrades Edwards Lifesciences to Market Perform From Outperform - MarketScreener
Edwards Lifesciences Corporation $EW Shares Bought by Mirova US LLC - MarketBeat
Shell Asset Management Co. Acquires 19,014 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW) Upgraded by Evercore ISI - GuruFocus
Edwards Lifesciences (EW) Receives Analyst Upgrade and Price Tar - GuruFocus
Edwards Lifesciences stock maintains Overweight rating ahead of PARTNER 3 data - Investing.com
Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition - Investing.com
Evercore ISI Upgrades Edwards Lifesciences to Outperform From In Line, Adjusts PT to $88 From $80 - MarketScreener
Seamount Financial Group Inc. Invests $259,000 in Edwards Lifesciences Corporation $EW - MarketBeat
QRG Capital Management Inc. Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Here's What To Expect From Edwards Lifesciences’ Next Earnings Report - Barchart.com
Edwards Lifesciences Corporation $EW Shares Bought by Comprehensive Financial Consultants Institutional Inc. - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Short Interest Update - MarketBeat
Edwards Lifesciences Corporation $EW Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
EW Investor News: If You Have Suffered Losses in Edwards - GlobeNewswire
Edwards Lifesciences Corporation $EW Shares Sold by OLD National Bancorp IN - MarketBeat
Hilltop National Bank Purchases Shares of 8,856 Edwards Lifesciences Corporation $EW - MarketBeat
Lbp Am Sa Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
River Street Advisors LLC Buys Shares of 5,240 Edwards Lifesciences Corporation $EW - MarketBeat
Cooper Financial Group Makes New $373,000 Investment in Edwards Lifesciences Corporation $EW - MarketBeat
17,034 Shares in Edwards Lifesciences Corporation $EW Bought by USA Financial Formulas - MarketBeat
What high frequency data says about Edwards Lifesciences CorporationJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Ninety One SA PTY Ltd Sells 5,206 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Ninety One UK Ltd Sells 64,875 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Park Avenue Securities LLC Makes New Investment in Edwards Lifesciences Corporation $EW - Defense World
Real time alert setup for Edwards Lifesciences Corporation performance2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences CorporationEW - MarketScreener
에드워즈라이프사이언시스 (EW) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.22%
1.21%
자본화:
|
볼륨(24시간):